Rhinitus/Sinusitis/Ocular Allergy News

Perrigo announced that the FDA has approved mometasone furoate monohydrate, an intranasal corticosteroid nasal spray designed to treat and prevent hay fever and allergy symptoms, for over-the-counter use.

Breastfeeding mitigated the risks for developing lower respiratory tract infections in infancy and for developing asthma and allergic rhinitis in childhood, according to a study published in The Journal of Allergy and Clinical Immunology.

AstraZeneca has received an FDA complete response letter concerning its supplemental biologics license application for benralizumab for the treatment of inadequately controlled chronic rhinosinusitis with nasal polyps.

PHOENIX — Wildfires outside of Monterey, Mexico, last spring had an impact on patients with respiratory allergies in the city, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

PHOENIX — Chronic rhinosinusitis and bronchiectasis as comorbidities in patients with asthma was associated with higher health care use, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

House dust mite sublingual immunotherapy tablets reduced inhaled corticosteroid use among patients with mild to moderate allergic asthma, according to a systematic review in The Journal of Allergy and Clinical Immunology: In Practice.

A dose of omalizumab administered before pollen season improved symptom control and quality of life compared with standard medication among patients with seasonal allergic rhinitis, according to a study in Clinical and Translational Allergy.

Common allergic conditions are more prevalent among nonwhite populations, which are underrepresented in many studies. But multiple strategies can improve their recruitment and retention, improving the value of study results, experts wrote.

Patients with moderate-to-severe asthma or chronic rhinosinusitis with nasal polyps experienced fewer respiratory infections with dupilumab, according to data published in The Journal of Allergy and Clinical Immunology: In Practice.

Septal deviation may be a treatable trait of asthma, with septoplasty reducing the risk, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.